Rare diseases
Investigational molecules
Locations
Back to Portugal680 clinical trials in Vila Nova De Gaia, Portugal. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PortugalEnsaios-Clinicos.pt(opens in a new tab)A study to test how well empagliflozin works and how safe it is for children and teenagers with chronic kidney disease
PortugalA study of ziltivekimab compared to placebo in people with heart and blood vessel disease, chronic kidney disease and inflammation
PortugalStudy of Izalontamab Brengitecan Compared to Standard Chemotherapy in Untreated Triple-negative or ER-low, HER2-negative Breast Cancer Patients Not Eligible for Anti-PD1/PD-L1 Treatment
PortugalLong-term safety study of ribociclib with letrozole, tamoxifen, or goserelin acetate in patients with HR-positive, HER2-negative advanced or metastatic breast cancer
PortugalStudy of bemarituzumab treatment for patients with solid tumors that have high levels of FGFR2b protein
PortugalLong-term safety study of NNC6019-0001 for patients with transthyretin amyloid cardiomyopathy (ATTR-CM)
PortugalComparison of oxazepam 50 mg orodispersible tablets and oxazepam 50 mg standard tablets in healthy volunteers to test if they work the same way in the body
PortugalStudy of cytisinicline and moxifloxacin effects on heart electrical activity in healthy smokers with nicotine addiction
PortugalStudy of AlloNK and rituximab with cyclophosphamide and fludarabine in adults with relapsing rheumatoid arthritis, inflammatory myopathies, systemic sclerosis, or Sjögren's disease
PortugalStudy of tarlatamab with durvalumab, carboplatin and etoposide versus standard treatment in patients with previously untreated extensive stage small cell lung cancer
PortugalLong-term safety study of pelacarsen in patients with atherosclerotic cardiovascular disease who completed the Lp(a)HORIZON trial
PortugalStudy of zolbetuximab, pembrolizumab and chemotherapy in adults with HER2-negative, Claudin 18.
PortugalThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on head and neck cancer, breast cancer, and multiple myeloma treatments. Studies include evaluations of novel therapies for both early-stage and metastatic conditions.
Research encompasses targeted therapies and combination treatments aimed at improving patient outcomes.
Comprehensive studies investigating treatments for various autoimmune conditions, including Sjögren's Syndrome and systemic sclerosis. Focus on developing targeted therapies for immune system regulation.
Evaluating novel biological therapies to address complex autoimmune manifestations.
Research focused on obesity management and cardiovascular health. Studies evaluate new therapeutic approaches for weight management and cardiovascular disease prevention.
Investigating innovative treatments to address growing metabolic health challenges.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
